Electrospinning is a fiber spinning technique, recognized as a simple and an efficient method for fabricating ultrafine fibers, the diameters of which range from a few micrometers down to tens of nanometers. In a typical process, an ultrafine stream of a polymeric liquid (solution or melt) is drawn continuously from the conical apex of its droplet by electrical forces and deposits randomly as a nonwoven fabric on a collection device (1,2). This is driven mainly by the Coulombic repulsion force between charges of the same polarity in the polymer liquid and the electrical force exerting on the charges by the electric field, which act to destabilize the partially-spherical droplet of the polymer liquid at the tip of the capillary to finally form a droplet with a conical shape. Due to its excellent biocompatibility, PLLA has been used extensively in medicine as surgical sutures (normally as a copolymer thread with glycolic acid) (4) and suture anchors (5). PLLA can be fabricated into fibrous matrices by electrospinning (6-14). Approved by the US Food and Drug Administration (US-FDA) for various clinical applications in humans (15), applicability of electrospun PLLA fibrous matrices in biomedicine is an obvious choice. Kenawy et al. (6) were the first group to report the use of electrospun fibrous matrices of poly(lactic acid) (PLA) and its blend with poly(ethylene-co-vinyl acetate) (PEVA) to encapsulate an anti-infection drug, tetracycline hydrochloride, and to study the release of the drug therefrom.